Founded
2020
Stage
Series A
Team size
10-30 employees
Sector
Health & Life Sciences
About
Synthetic biology company developing small-molecule therapeutics against historically undruggable proteins using microbial systems for drug discovery.
Funding
Last roundSeries A
Amount raised$55M
Funding detail is compiled from public sources and may lag recent activity.